CO6210818A2 - Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñas - Google Patents
Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñasInfo
- Publication number
- CO6210818A2 CO6210818A2 CO09093298A CO09093298A CO6210818A2 CO 6210818 A2 CO6210818 A2 CO 6210818A2 CO 09093298 A CO09093298 A CO 09093298A CO 09093298 A CO09093298 A CO 09093298A CO 6210818 A2 CO6210818 A2 CO 6210818A2
- Authority
- CO
- Colombia
- Prior art keywords
- chitosan
- aminopolysaccharide
- physiologically acceptable
- acceptable salts
- agents
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 229920001661 Chitosan Polymers 0.000 abstract 20
- 150000003839 salts Chemical class 0.000 abstract 8
- 239000004480 active ingredient Substances 0.000 abstract 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005711 Benzoic acid Substances 0.000 abstract 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
- 108010036949 Cyclosporine Proteins 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 241000195950 Equisetum arvense Species 0.000 abstract 1
- 239000005768 Equisetum arvense L. Substances 0.000 abstract 1
- 241000207963 Harpagophytum Species 0.000 abstract 1
- 239000004909 Moisturizer Substances 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 229960005339 acitretin Drugs 0.000 abstract 1
- IHUNBGSDBOWDMA-AQFIFDHZSA-N all-trans-acitretin Chemical compound COC1=CC(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1C IHUNBGSDBOWDMA-AQFIFDHZSA-N 0.000 abstract 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 1
- 208000004631 alopecia areata Diseases 0.000 abstract 1
- 230000002682 anti-psoriatic effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 235000010233 benzoic acid Nutrition 0.000 abstract 1
- 229960002537 betamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical group C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- 229960002882 calcipotriol Drugs 0.000 abstract 1
- LWQQLNNNIPYSNX-UROSTWAQSA-N calcipotriol Chemical compound C1([C@H](O)/C=C/[C@@H](C)[C@@H]2[C@]3(CCCC(/[C@@H]3CC2)=C\C=C\2C([C@@H](O)C[C@H](O)C/2)=C)C)CC1 LWQQLNNNIPYSNX-UROSTWAQSA-N 0.000 abstract 1
- 229960005084 calcitriol Drugs 0.000 abstract 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
- 235000020964 calcitriol Nutrition 0.000 abstract 1
- 239000011612 calcitriol Substances 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 229960001265 ciclosporin Drugs 0.000 abstract 1
- 229960002842 clobetasol Drugs 0.000 abstract 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 229930182912 cyclosporin Natural products 0.000 abstract 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001259 diclofenac Drugs 0.000 abstract 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 239000003410 keratolytic agent Substances 0.000 abstract 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 abstract 1
- 229960000991 ketoprofen Drugs 0.000 abstract 1
- 201000011486 lichen planus Diseases 0.000 abstract 1
- 230000001333 moisturizer Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 229960001727 tretinoin Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07102338A EP1958639A1 (en) | 2007-02-14 | 2007-02-14 | Use of chitosans for the treatment of nail inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6210818A2 true CO6210818A2 (es) | 2010-10-20 |
Family
ID=38212471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09093298A CO6210818A2 (es) | 2007-02-14 | 2009-09-02 | Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñas |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8906881B2 (enExample) |
| EP (3) | EP1958639A1 (enExample) |
| JP (3) | JP2010518139A (enExample) |
| KR (1) | KR101468479B1 (enExample) |
| CN (1) | CN101641103B (enExample) |
| AR (1) | AR065317A1 (enExample) |
| AU (1) | AU2008214695B2 (enExample) |
| BR (1) | BRPI0807596A2 (enExample) |
| CA (1) | CA2676259C (enExample) |
| CL (1) | CL2008000443A1 (enExample) |
| CO (1) | CO6210818A2 (enExample) |
| CY (1) | CY1113822T1 (enExample) |
| DK (1) | DK2117565T3 (enExample) |
| EA (1) | EA019539B1 (enExample) |
| EC (1) | ECSP099631A (enExample) |
| ES (1) | ES2394169T3 (enExample) |
| HR (1) | HRP20120915T1 (enExample) |
| IL (1) | IL200091A (enExample) |
| MA (1) | MA31237B1 (enExample) |
| ME (1) | ME00828B (enExample) |
| MX (1) | MX2009008514A (enExample) |
| MY (1) | MY150502A (enExample) |
| NZ (1) | NZ578937A (enExample) |
| PL (1) | PL2117565T3 (enExample) |
| PT (1) | PT2117565E (enExample) |
| RS (1) | RS52620B (enExample) |
| SI (1) | SI2117565T1 (enExample) |
| UA (1) | UA101151C2 (enExample) |
| WO (1) | WO2008098871A2 (enExample) |
| ZA (1) | ZA200904975B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
| CA2622204C (en) | 2005-09-12 | 2016-10-11 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same |
| US9427419B2 (en) | 2005-09-12 | 2016-08-30 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (DMSO) |
| US10201490B2 (en) * | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
| CA2749141A1 (en) * | 2009-01-08 | 2010-07-15 | Allergan, Inc. | Cyclosporine compositions for enhancing nail growth |
| AU2010313253B2 (en) | 2009-10-30 | 2015-02-19 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| EA033767B1 (ru) * | 2014-06-10 | 2019-11-22 | Makhbuba Nabi Kyzy Velieva | Средство против выпадения волос на основе лекарственных растений |
| PL233616B1 (pl) | 2017-08-10 | 2019-11-29 | Podopharm Spolka Z Ograniczona Odpowiedzialnoscia | Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu |
| KR102511613B1 (ko) * | 2019-09-23 | 2023-03-17 | 포항공과대학교 산학협력단 | 키토산을 포함하는 면역억제용 조성물 및 이의 용도 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE378109B (enExample) | 1972-05-19 | 1975-08-18 | Bofors Ab | |
| DE3541305A1 (de) | 1985-11-22 | 1987-05-27 | Wella Ag | Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung |
| JPH08245401A (ja) * | 1995-03-14 | 1996-09-24 | Osamu Hatanaka | 皮膚保護剤 |
| SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
| US7147854B2 (en) * | 1997-06-23 | 2006-12-12 | Yes Biotech Laboratories Ltd. | Topical treatment of psoriasis using neutralizing antibodies to interleukin-8 |
| JP4185173B2 (ja) | 1997-08-07 | 2008-11-26 | 株式会社ノエビア | 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤 |
| DE59911740D1 (de) * | 1998-09-10 | 2005-04-14 | Bioequal Ag Muttenz | Topisch anwendbare mittel gegen nagelpilzerkrankungen |
| DE19911056B9 (de) | 1999-03-12 | 2005-09-08 | Biotec Asa | Kosmetische Zubereitungen und deren Verwendung |
| JP2001055335A (ja) * | 1999-08-18 | 2001-02-27 | Toshio Sato | アレルギー性皮膚疾患治療剤 |
| JP2001131030A (ja) * | 1999-11-08 | 2001-05-15 | Kureha Chem Ind Co Ltd | 発毛促進剤 |
| DE10035991A1 (de) | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| NO20005718A (no) | 2000-11-13 | 2001-06-05 | Ethics Cosmeceuticals Ab | Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugert vitamin A samt fremgangsmåte for fremstilling og anvendelse av denne |
| KR20020048534A (ko) | 2000-12-18 | 2002-06-24 | 안병로 | 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제 |
| SE0100166D0 (sv) | 2001-01-22 | 2001-01-22 | Tacton Systems Ab | Configuration system |
| KR100457546B1 (ko) | 2001-05-02 | 2004-11-18 | 주식회사 바이오프로젠 | 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법 |
| GB0126923D0 (en) | 2001-11-09 | 2002-01-02 | Procter & Gamble | Chitosan compositions |
| EP1455802B1 (en) * | 2001-12-14 | 2008-10-15 | Dnp Canada Inc. | Uses of chitosan oligosaccharides |
| KR100470753B1 (ko) * | 2003-01-09 | 2005-03-10 | 주식회사 자광 | 수용성 천연필름과 그의 제조방법 |
| JP2004231604A (ja) | 2003-01-31 | 2004-08-19 | Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai | 担体シートおよび徐放性製剤ならびにそれらの製法 |
| EP1491202A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
| US20050112151A1 (en) | 2003-11-20 | 2005-05-26 | Horng Liou L. | Skin adherent hydrogels |
| RU2258516C1 (ru) * | 2004-01-20 | 2005-08-20 | Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" | Способ лечения красного плоского лишая |
| JP2005306746A (ja) | 2004-04-19 | 2005-11-04 | Jiyugaoka Clinic | 顔面用シワ治療剤 |
| US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| JP4804770B2 (ja) * | 2005-02-28 | 2011-11-02 | 株式会社アリミノ | ヘアーコンディショニング剤およびその使用方法 |
| WO2006111426A1 (en) * | 2005-04-19 | 2006-10-26 | Galderma S.A. | Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology |
| JP5632125B2 (ja) | 2005-06-14 | 2014-11-26 | ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． | 部分的脱アセチル化キチン誘導体の組成物 |
| FR2892023B1 (fr) * | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
| EP1842545A1 (en) * | 2006-04-04 | 2007-10-10 | Marinomed Biotechnologie GmbH | Anti-inflammatory polymer |
| DE102006049585A1 (de) * | 2006-10-22 | 2008-04-24 | Susilo, Rudy, Dr. | Nagellack für kosmetische und medizinische Anwendungen |
-
2007
- 2007-02-14 EP EP07102338A patent/EP1958639A1/en not_active Withdrawn
-
2008
- 2008-02-07 JP JP2009549396A patent/JP2010518139A/ja active Pending
- 2008-02-07 ES ES08735410T patent/ES2394169T3/es active Active
- 2008-02-07 HR HRP20120915AT patent/HRP20120915T1/hr unknown
- 2008-02-07 US US12/449,540 patent/US8906881B2/en not_active Expired - Fee Related
- 2008-02-07 BR BRPI0807596-4A patent/BRPI0807596A2/pt not_active Application Discontinuation
- 2008-02-07 CN CN2008800050836A patent/CN101641103B/zh not_active Expired - Fee Related
- 2008-02-07 EA EA200901113A patent/EA019539B1/ru not_active IP Right Cessation
- 2008-02-07 PT PT87354106T patent/PT2117565E/pt unknown
- 2008-02-07 KR KR1020097018463A patent/KR101468479B1/ko not_active Expired - Fee Related
- 2008-02-07 EP EP12155609A patent/EP2455086A1/en not_active Withdrawn
- 2008-02-07 MY MYPI20093346 patent/MY150502A/en unknown
- 2008-02-07 PL PL08735410T patent/PL2117565T3/pl unknown
- 2008-02-07 MX MX2009008514A patent/MX2009008514A/es active IP Right Grant
- 2008-02-07 CA CA2676259A patent/CA2676259C/en not_active Expired - Fee Related
- 2008-02-07 ZA ZA200904975A patent/ZA200904975B/xx unknown
- 2008-02-07 NZ NZ578937A patent/NZ578937A/en not_active IP Right Cessation
- 2008-02-07 UA UAA200908421A patent/UA101151C2/ru unknown
- 2008-02-07 SI SI200830843T patent/SI2117565T1/sl unknown
- 2008-02-07 AU AU2008214695A patent/AU2008214695B2/en not_active Ceased
- 2008-02-07 EP EP08735410A patent/EP2117565B1/en active Active
- 2008-02-07 WO PCT/EP2008/051479 patent/WO2008098871A2/en not_active Ceased
- 2008-02-07 RS RS20120575A patent/RS52620B/sr unknown
- 2008-02-07 DK DK08735410.6T patent/DK2117565T3/da active
- 2008-02-07 ME MEP-2009-268A patent/ME00828B/me unknown
- 2008-02-12 CL CL200800443A patent/CL2008000443A1/es unknown
- 2008-02-12 AR ARP080100603A patent/AR065317A1/es not_active Application Discontinuation
-
2009
- 2009-07-27 IL IL200091A patent/IL200091A/en active IP Right Grant
- 2009-09-02 CO CO09093298A patent/CO6210818A2/es not_active Application Discontinuation
- 2009-09-04 MA MA32201A patent/MA31237B1/fr unknown
- 2009-09-14 EC EC2009009631A patent/ECSP099631A/es unknown
-
2013
- 2013-01-14 CY CY20131100040T patent/CY1113822T1/el unknown
-
2014
- 2014-08-08 JP JP2014162698A patent/JP6035292B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-05 JP JP2016155046A patent/JP2016188252A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6210818A2 (es) | Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñas | |
| JP2010518139A5 (enExample) | ||
| CL2019000431A1 (es) | Tetrahidro-pirido[3,4-b]indoles moduladores de receptores de estrógenos y usos de los mismos. (divisional solicitud 201700814) | |
| MX2018011278A (es) | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. | |
| MX353154B (es) | Emulsiones de aceite/agua que comprenden alcanos semifluorados. | |
| CO6150136A2 (es) | Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acne | |
| BR112016002915A2 (pt) | formulação agroquímica pulverizável, formulação concentrada, uso de um éster graxo de um poliol c3 a c8, ou oligômero do mesmo, e, métodos para reduzir o desvio de pulverização e para tratamento de vegetação para controlar pestes e/ou fornecer nutrientes | |
| CO6220926A2 (es) | Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid) | |
| ECSP088490A (es) | Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico | |
| MX366773B (es) | Composicion topica para lavado para su uso en pacientes con acne. | |
| CO6300927A2 (es) | Sales de arginina y un cation, productos de cuidado oral y personal que los contienen y metodos para preparar dichas sales y productos | |
| AR065316A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologiamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| BR112015022747A8 (pt) | kit para prevenção de estenose e uso de um peptídeo de automontagem | |
| GT201400069A (es) | Composiciones farmaceuticas | |
| BR112012029064A2 (pt) | formulação farmacêutica na forma de comprimidos de duas camadas compreendendo inibidores da hmg-coa redutase e irbesartan | |
| NI200700031A (es) | Formulaciones de ácido hidroxamico suberoilanilida y procedimientos para la producción de las mismas | |
| DOP2010000135A (es) | Acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465 | |
| ATE505477T1 (de) | Amorphe form von (11beta,16alpha)-9-fluoro-11- | |
| CL2007003680A1 (es) | Sales de isoglutamil-d-triptofano; proceso de preparacion de dichas sales; composicion farmaceutica que comprende a dichas sales; proceso de preparacion de la composicion farmaceutica; utiles para el tratamiento de psoriasis y dermatitis atopica. | |
| AR094027A1 (es) | Formulaciones topicas que contienen pidotimod | |
| UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones | |
| AR077451A1 (es) | Utilizacion de benzidamina en el tratamiento de enfermedades dependientes de p40 | |
| AR054361A1 (es) | Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas | |
| AR086252A1 (es) | Formulacion topica que comprende dipropionato de beclometasona como ingrediente activo | |
| PE20070012A1 (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil) ftalazin-1-ilo] micronizado, y sus sales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |